Therapeutics. XVII. "Reserve" drugs in the treatment of tuberculosis.
D056486:Chemical and Drug Induced Liver Injury; D003365:Costs and Cost Analysis; D003875:Drug Eruptions; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008099:Liver / Q000187:drug effects; D009902:Optic Neuritis / Q000139:chemically induced; D012293:Rifampin / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D013828:Thioacetazone / Q000009:adverse effects / Q000627:therapeutic use*; D014376:Tuberculosis / Q000188:drug therapy*
D004977:Ethambutol; D013828:Thioacetazone; D012293:Rifampin